gvtcx

supplier

Amgen Ltd

CB40WA combined from 3 published records

as a supplier

66 recorded awards from 11 buyers , between 10 Aug 2017 and 3 Jun 2026.

awards won
66
exclusive
3%
2 sole-winner awards
median award
£261.9m
largest
£986.3m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
Transitional Drugs 7 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £16,804,001 3 Jun 2026
Ustekinumab shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £6,532,463 3 Jun 2026
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 shared NHS England £813,863,584 31 May 2026
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 shared NHS England £18,903,212 31 May 2026
Transitional Drugs 6 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £1,637,728 29 Jan 2026
NHS National Framework for Denosumab Injection commencing 1st January 2026 shared NHS England £15,059,000 29 Sept 2025
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 shared NHS England £986,282,758 30 Jun 2025
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National shared NHS England £261,895,933 24 Jun 2025
CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab shared NHS England £230,000,000 12 Aug 2024
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche shared NHS England £261,970,000 8 Feb 2023
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual shared NHS England £216,078,796 7 Feb 2022
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche shared NHS England £1 11 Feb 2021
NHS Framework Colorectal Cancer Drugs (See description below) shared NHS England £75,000,000 13 Nov 2020
NHS Framework for the NHS London Region, Branded Medicines - Tranche A shared NHS England £191,062,951 16 Jun 2020
NHS National Framework Agreement for Adalimumab Injection shared NHS England £445,000,000 6 Mar 2020
NHS Midlands and East Branded Medicines - Tranche A shared NHS England £418,787,000 15 Jan 2020
NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice shared NHS England £188,004,961 31 Jul 2019
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity shared NHS England £251,930,337 4 Jul 2019
NHS Framework agreement for Branded Medicines - North of England - Tranche A shared NHS England £204,551,038 18 Feb 2019
NHS England - Midlands and East Branded Medicines - Tranche B shared NHS England £295,035,882 17 Jan 2019
NHS England Framework Agreement - London - Tranche A shared NHS England £211,435,404 14 Aug 2018

every contract won by Amgen Ltd →

as published

This page combines 3 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Amgen Ltd · · 48
AMGEN LIMITED GB-PPON PDJG-8184-TCQQ CB4 0WA 9
Amgen Ltd. GB-COH 02354269 · 9

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works